These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 571314)

  • 1. Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids.
    El Makhzangy MN; Wynn V; Lawrence DM
    Clin Endocrinol (Oxf); 1979 Jan; 10(1):39-45. PubMed ID: 571314
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of varying amounts of ethinyl oestradiol in the combined oral contraceptive on plasma sex hormone binding globulin capacity in normal women.
    Pogmore JR; Jequier AM
    Br J Obstet Gynaecol; 1979 Jul; 86(7):563-7. PubMed ID: 573132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
    De Leo V; Di Sabatino A; Musacchio MC; Morgante G; Scolaro V; Cianci A; Petraglia F
    Contraception; 2010 Sep; 82(3):276-80. PubMed ID: 20705157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in coagulation and fibrinolysis variables during use of two oral contraceptives containing the same dose of ethinyl estradiol and either gestodene or desogestrel.
    Gevers Leuven JA; Kluft C; Dersjant-Roorda MC; Harthoorn-Lasthuizen EJ; Peters FP; Bernsen MJ; Helmerhorst FM
    Adv Contracept; 1990 Dec; 6 Suppl():69-73. PubMed ID: 2149807
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of an oral contraceptive containing a new progestogen, desogestrel, and 30 micrograms ethinylestradiol. Report on clinical studies from Scandinavia.
    Acta Obstet Gynecol Scand Suppl; 1982; 111():1-60. PubMed ID: 6216716
    [No Abstract]   [Full Text] [Related]  

  • 8. Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ethinyl estradiol (Femovan) or a combination of desogestrel/ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives.
    Hümpel M; Täuber U; Kuhnz W; Pfeffer M; Brill K; Heithecker R; Louton T; Steinberg B; Seifert W; Schütt B
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):329-33. PubMed ID: 2142574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestagen-dependent effect on some plasma proteins during oral contraception.
    Liukko P; Erkkola R; Bergink EW
    Gynecol Obstet Invest; 1988; 25(2):118-22. PubMed ID: 2967233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR; Gaspard UJ
    Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone.
    Jung-Hoffmann C; Kuhl H
    Am J Obstet Gynecol; 1987 Jan; 156(1):199-203. PubMed ID: 2948387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral parameters of the menstrual cycle under the influence of a new combined oral contraceptive.
    Spona J; Schneider WH
    Acta Obstet Gynecol Scand Suppl; 1976; 54():45-50. PubMed ID: 788444
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular biology and oral contraception.
    Briggs MH; Briggs M
    N Z Med J; 1976 Apr; 83(562):257-61. PubMed ID: 183175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L
    Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ampicillin on oral contraceptive effectiveness.
    Friedman CI; Huneke AL; Kim MH; Powell J
    Obstet Gynecol; 1980 Jan; 55(1):33-7. PubMed ID: 7188714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
    Siegberg R; Nilsson CG; Stenman UH; Widholm O
    Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and sex hormone binding globulin capacity.
    Masurkar KG; Joshi UM
    Indian J Med Res; 1980 Feb; 71():221-4. PubMed ID: 7189743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
    Jung-Hoffmann C; Fitzner M; Kuhl H
    Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.